Skip to Content
  • A 2.3 Billion Dollar Attention-Getter

    No sooner do I write another post about pharma marketing than Pfizer finds itself paying 3.2 2.3 billion dollars in fines for doing it improperly. 1.2 billion o… Read More
  • Ghostwriting

    As much as I defend the industry I work in, I have to talk about things that we do that I don’t think are so defensible. Another one of those has come up… Read More
  • Selling Zyprexa

    Well, this doesn’t look good for Lilly. A huge pile of court documents has been unsealed in the ongoing lawsuits about Zyprexa’s off-label promotion… Read More
  • Word For Word – But Why?

    I missed this a couple of months ago, but there was a paper withdrawn from the Journal of Organic Chemistry. The original is here, a contribution from the India… Read More
  • Merck, Elsevier, and Fakery

    I’ve been meaning to write about the latest advance in salesmanship, pioneered by Merck and Elsevier. As most of you will have heard, the two collaborated… Read More
Page 20 of 23« First...10...1819202122...Last »